Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Share Buyback Program

19 Dec 2025 07:21

RNS Number : 2789M
Banco Bilbao Vizcaya Argentaria SA
19 December 2025
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Company"), in compliance with the Spanish Securities Market legislation, hereby proceeds to notify the following:

 

 

INSIDE INFORMATION

 

Further to the notice of inside information of 16 October 2025, with CNMV registration number 2942, BBVA has received the required authorization from the European Central Bank for the buyback and cancellation of own shares of BBVA for a maximum aggregate amount of 3,960 million euros, in one or several tranches and until 8 December 2026 (the "Authorization"). The maximum amount of 3,960 million euros has been fully deducted from BBVA's individual and consolidated common equity tier 1 (CET1) as from the Authorization receipt.

 

Once the Authorization has been obtained, and in exercise of the authority delegated to it by the Annual Shareholders' Meeting of BBVA held on 18 March 2022, the Board of Directors of BBVA, in its meeting held on 18 December 2025, has agreed to carry out a program scheme for the buyback of own shares in accordance with the provisions of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016 (together the "Regulations"), which will be executed in several tranches, for a maximum aggregate amount of up to 3,960 million euros, aimed at reducing BBVA's share capital (the "Program Scheme"), notwithstanding the possibility to suspend or early terminate the Program Scheme upon the occurrence of circumstances that make it advisable.

 

Likewise, the Board of Directors has agreed, within the scope of the Program Scheme, to carry out a first tranche in accordance with the provisions of the Regulations with a view to reducing the share capital of BBVA (the "First Tranche") and with the terms and conditions detailed below:

Purpose:

To reduce BBVA's share capital by cancelling the shares acquired.

 

Maximum cash amount:

 

The maximum aggregate cash amount will be 1,500,000,000 euros.

Maximum number of shares:

The maximum number of BBVA shares to be acquired will be 557,316,433.

 

Start of the execution:

Execution will start on 22 December 2025.

End of the execution:

The First Tranche will end neither before 6 March 2026 nor later than 7 April 2026[1] and, in any event, when within such period the maximum cash amount is reached or the maximum number of shares is acquired.

 

However, the Company reserves the right to temporarily suspend execution of the First Tranche or end it early in the event of any circumstance that so advises or requires.

 

Trading Venues:

Purchases shall be made on the Spanish electronic trading system - Continuous Market and on the Cboe Europe, Turquoise Europe and Aquis Exchange trading platforms.

 

Manager:

The First Tranche will be executed externally through J.P. Morgan SE, which will decide independently of the Company on the timing of the purchases of BBVA shares.

 

Minimum Number of Shares Per Day

The Manager shall purchase at least 500,000 BBVA shares on each Trading Day (which is not an Excluded Day nor a Disrupted Day[2]), unless the Manager determines that it would not be possible to achieve the Minimum Number of Shares Per Day without breaching the restrictions and limitations under Delegated Regulation (EU) 2016/1052. Any such occurrence shall be duly disclosed in the periodic communications made in accordance with the Regulations, stating the reason why the Minimum Number of Shares Per Day was not purchased.

 

Other conditions:

The own shares will be purchased observing in all cases the conditions and limits established in the Regulations.

 

The share purchase transactions performed, as well as the end or, as the case may be, the temporary suspension of execution of the First Tranche, will be duly communicated in accordance with the Regulations.

 

 

Madrid, 19 December 2025


[1] However, for each "Excluded Day," the execution period may be postponed by one "Trading Day," up to a maximum postponement until 21 April 2026.

 

A "Trading Day" means each day on which the Continuous Market is scheduled to be open for trading during normal market hours.

 

An "Excluded Day" means any Trading Day on which: (i) any Trading Venue does not open for the entire regular trading session; or (ii) a suspension or limitation on the trading of BBVA shares is imposed on any Trading Venue for the entire regular trading session; or (iii) the trading price of BBVA shares on any Trading Venue is below their nominal value for the entire regular trading session; or (iv) the Company has suspended the execution of the First Tranche.

 

[2] "Disrupted Day" means any Trading Day on which: (i) any Trading Venue is closed for a substantial part of its regular trading session or closes significantly earlier than its scheduled closing time, or there is a significant disruption to trading on any Trading Venue; or (ii) any Trading Venue imposes a suspension or limitation on the trading of BBVA shares for a substantial part of the regular trading session; or (iii) the trading price of BBVA shares on any Trading Venue is below their nominal value for a substantial part of the regular trading session.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKABRVWUUARA
Date   Source Headline
30th Mar 20177:00 amRNSDividend Option Information April 2017
22nd Mar 20178:12 amRNSBBVA completes the acquisition of 9.95% of Garanti
20th Mar 20177:00 amRNSBasel Accord Pillar III
17th Mar 20173:05 pmRNSDividend Option April 2017
17th Mar 20172:58 pmRNSResolutions adopted by the General Meeting
16th Mar 20171:36 pmRNSFinal Terms GMTN Programme
14th Mar 20173:55 pmRNSFinal Terms GMTN Programme
8th Mar 201711:36 amRNSDBRS has assigned BBVA an Issuer Rating
24th Feb 20173:49 pmRNSSupplemental to the Offering Circular GMTN
24th Feb 201710:29 amRNSFinal Terms GMTN Programme
22nd Feb 20177:00 amRNSAcquisition agreement 9,95% of Garanti
14th Feb 20174:07 pmRNSSupplemental to the Offering Circular
14th Feb 20171:26 pmRNSBBVA Annual Report 2016 (spanish version)
14th Feb 20171:22 pmRNSBBVA Annual Report 2016
14th Feb 20179:06 amRNSNotice of AGM
10th Feb 20177:00 amRNSAnnual General Meeting 2017 Call
8th Feb 20173:04 pmRNSFinal Terms - Global Medium Term Note Programme
6th Feb 201710:15 amRNSPost-Stab Notice BBVA EUR 5yr Senior
3rd Feb 20173:34 pmRNSStabilisation Notice
2nd Feb 20178:37 amRNSStabilisation Notice - BBVA T2
1st Feb 20174:36 pmRNSSupplemental to the Offering Circular
1st Feb 20177:16 amRNS4Q16 Results Presentation
1st Feb 20177:10 amRNS4Q16 Results Report
1st Feb 20177:05 amRNSPress Release 4Q16 Results
1st Feb 20177:00 amRNSShareholder Remuneration Policy
27th Jan 20177:48 amRNS4Q16 Results presentation announcement
23rd Jan 20177:46 amRNSRDL Mortgage Floor Clauses
11th Jan 201712:09 pmRNSFinal Terms Global Medium Term Note Programme
5th Jan 201710:10 amRNSPre Stabilisation Notice BBVA EUR 5yr Senior
4th Jan 20173:21 pmRNSPublication of Approved ECP Supplement
28th Dec 20167:00 amRNSSupplemental to the Offering Circular
22nd Dec 20163:51 pmRNSPublication of approved ECP Listing Particulars
22nd Dec 20167:00 amRNSDividend January 2017
21st Dec 20162:23 pmRNSMortgage Floor Clauses
19th Dec 201610:43 amRNSSupplemental to the Offering Circular
1st Dec 20167:48 amRNSSREP capital requirement
25th Nov 20161:24 pmRNSOffering Circular
23rd Nov 20165:44 pmRNSBBVA SA Annual Report 2015
23rd Nov 20165:28 pmRNSBBVA SA Annual Report 2014
23rd Nov 20165:19 pmRNSForm 6-K
23rd Nov 20165:04 pmRNSForm 20-F 2015
7th Nov 20163:32 pmRNSSupplemental to the Offering Circular
4th Nov 201612:18 pmRNSDividend Option
27th Oct 20167:00 amRNS3rd Quarter Results Presentation
27th Oct 20167:00 amRNS3rd Quarter Results Information
27th Oct 20167:00 amRNS3rd Quarter Results
24th Oct 20165:02 pmRNSHR 3Q16 Results presentation announcement
20th Oct 20167:00 amRNSEnding trading period Divend Option October 2016
29th Sep 20167:00 amRNSDividend Option Information October 2016
16th Sep 20161:43 pmRNSDividend Option Calendar October 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.